Two predominant molecular subtypes of spinal meningioma: thoracic NF2-mutant tumors strongly associated with female sex, and cervical AKT1-mutant tumors originating ventral to the spinal cord

Affiliations

¹ Department of Neurosurgery, Huashan Hospital, Shanghai Medical College, Fudan University, Shanghai, China. lyhua15@fudan.edu.cn.
² Department of Neurosurgery, Carl Gustav Carus University Hospital, TU Dresden, Dresden, Germany.
³ Department for Pathology, Carl Gustav Carus University Hospital, TU Dresden, Dresden, Germany.
⁴ Core Unit for Molecular Tumor Diagnostics (CMTD), National Center for Tumor Diseases Dresden (NCT/UCC), Dresden, Germany.
⁵ Department of Neurosurgery, Translational Neuro-Oncology Laboratory, Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA, USA.
⁶ Department of Medicine, Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA, USA.
⁷ Department of Neurosurgery, Huashan Hospital, Shanghai Medical College, Fudan University, Shanghai, China.
⁸ Department of Neurosurgery, Carl Gustav Carus University Hospital, TU Dresden, Dresden, Germany. Tareq.Juratli@ukdd.de.
⁹ Department of Neurosurgery, Translational Neuro-Oncology Laboratory, Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA, USA. Tareq.Juratli@ukdd.de.

Lingyang Hua et al. Acta Neuropathol. 2022 Nov.

. 2022 Nov;144(5):1053-1055.

doi: 10.1007/s00401-022-02474-9. Epub 2022 Aug 9.

¹ Department of Neurosurgery, Huashan Hospital, Shanghai Medical College, Fudan University, Shanghai, China. lyhua15@fudan.edu.cn.
² Department of Neurosurgery, Carl Gustav Carus University Hospital, TU Dresden, Dresden, Germany.
³ Department for Pathology, Carl Gustav Carus University Hospital, TU Dresden, Dresden, Germany.
⁴ Core Unit for Molecular Tumor Diagnostics (CMTD), National Center for Tumor Diseases Dresden (NCT/UCC), Dresden, Germany.
⁵ Department of Neurosurgery, Translational Neuro-Oncology Laboratory, Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA, USA.
⁶ Department of Medicine, Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA, USA.
⁷ Department of Neurosurgery, Huashan Hospital, Shanghai Medical College, Fudan University, Shanghai, China.
⁸ Department of Neurosurgery, Carl Gustav Carus University Hospital, TU Dresden, Dresden, Germany. Tareq.Juratli@ukdd.de.
⁹ Department of Neurosurgery, Translational Neuro-Oncology Laboratory, Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA, USA. Tareq.Juratli@ukdd.de.

No abstract available

Figures

1. Arslantas A, et al. Detection of chromosomal imbalances in spinal meningiomas by comparative genomic hybridization. Neurol Med Chir (Tokyo) 2003;43(1):12–18. doi: 10.2176/nmc.43.12. - DOI - PubMed
1. Bacci C, et al. Schwannomatosis associated with multiple meningiomas due to a familial SMARCB1 mutation. Neurogenetics. 2010;11(1):73–80. doi: 10.1007/s10048-009-0204-2. - DOI - PubMed
1. Brastianos PK, et al. Genomic sequencing of meningiomas identifies oncogenic SMO and AKT1 mutations. Nat Genet. 2013;45(3):285–289. doi: 10.1038/ng.2526. - DOI - PMC - PubMed
1. Champeaux-Depond C, Weller J, Resche-Rigon M. Neurofibromatosis type 2: a nationwide population-based study focused on survival after meningioma surgery. Clin Neurol Neurosurg. 2020;198:106236. doi: 10.1016/j.clineuro.2020.106236. - DOI - PubMed
1. Clark VE, et al. Genomic analysis of non-NF2 meningiomas reveals mutations in TRAF7, KLF4, AKT1, and SMO. Science. 2013;339(6123):1077–1080. doi: 10.1126/science.1233009. - DOI - PMC - PubMed